All Report
Whether you’re exploring new opportunities, responding to change, or planning your next move—we’re here to help you make sense of it all. Our research goes beyond data to uncover real market signals, emerging trends, competitive shifts, and what they mean for your business. With practical insights and a partner mindset, we support you in making smarter, faster, and more confident decisions.
The global vein illuminator market is on track to witness significant expansion, projected to grow from USD 209.5 million in 2025 to USD 1,701 million by 2035, at a 24.3% CAGR over the forecast period.
The global venous stents market is projected to experience robust growth, reaching USD 3.2 billion by 2035, up from USD 1.99 billion in 2025, with an estimated CAGR of 9.4% during the forecast period.
The global venous thromboembolism (VTE) treatment market is projected to grow from USD 1.76 billion in 2024 to USD 2.68 billion by 2034, registering a CAGR of 4.9% during the forecast period.
The global venous ulcer treatment market is set to expand significantly, reaching USD 3.97 billion in 2025 and projected to grow to USD 8.61 billion by 2035, with an expected 7.5% CAGR.
The global ventral hernia treatment market is projected to witness substantial growth, reaching USD 10.4 billion by 2035, up from USD 6.05 billion in 2025, at an estimated CAGR of 7.4% over the forecast period.
The global ventricular fibrillation treatment market is projected to reach a valuation of USD 10.19 billion in 2024, growing at a 9.5% CAGR, to reach USD 21.78 billion by 2034.
The global vernal keratoconjunctivitis market is expected to witness substantial growth, increasing from USD 437.9 million in 2025 to USD 783.42 million by 2035, registering a 7% CAGR during the forecast period.
The global vertebroplasty needles market is poised for substantial growth, projected to reach USD 3.71 billion by 2035, up from USD 1.91 billion in 2025, expanding at a CAGR of 16.1% during the forecast period.
The global vessel-sealing devices market is projected to experience significant growth, reaching USD 4,896.44 million by 2035 from USD 2,645.90 million in 2025, expanding at a 10% CAGR during the forecast period.
The global vestibular testing system market is expected to grow significantly, reaching USD 203.4 million by 2035, up from USD 120.3 million in 2025, with a CAGR of 6.4% during the forecast period.